Strategies for dealing with missing data in clinical trials: From design to analysis

Yale Journal of Biology and Medicine

Volumn 86, Issue 3, 2013, Pages 343-358

  Dziura, James D ^a,b   Post, Lori A ^a   Zhao, Qing ^b   Fu, Zhixuan ^b   Peduzzi, Peter ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Clinical trial; Intent to treat; MAR; MCAR; Missing data; MNAR; Study design

Indexed keywords

BODY FAT; CASE STUDY; CERTIFICATION; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DATA COLLECTION METHOD; FOLLOW UP; HUMAN; INFORMED CONSENT; PILOT STUDY; PRACTICE GUIDELINE; PREDICTION; REVIEW; RISK ASSESSMENT; STRATEGIC PLANNING; STUDY DESIGN; TREATMENT OUTCOME;

CLINICAL TRIAL; INTENT TO TREAT; MAR; MCAR; MISSING DATA; MNAR; STUDY DESIGN;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; HUMANS; RESEARCH DESIGN;

EID: 84884486714     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Dreyer NA, Tunis SR, Berger M, Ollendorf D, Mattox P, Gliklich R. Why observational studies should be among the tools used in comparative effectiveness research. Health Aff (Millwood). 2010;29(10):1818-25.
2. Kaplan BJ, Giesbrecht G, Shannon S, McLeod K. Evaluating treatments in health care: The instability of a one-legged stool. BMC Med Res Methodol. 2011;11:65.
3. Simon R. Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology. Per Med. 2010;7(1):33-47.
4. Hennekens CH, DeMets D. Statistical Association and Causation Contributions of Different Types of Evidence. JAMA. 2011;305(11):1134-5.
5. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. March 2012. Available from: http://www.effect iveheal thcare.ahrq.gov/ehc/products/322/998/MethodsGuideforCERs_Viswan athan_IndividualStudies.pdf.
6. Scharfstein S, Neaton J, Hogan J, Little R, Daniels M, Roy J, et al. Minimal Standards in the Prevention and Handling of Missing Data in Observational and Experimental Patient Centered Outcomes Research [Internet]. 2012 Mar 15. Available from: http://www.pcori.org/assets/ Minimal-Standards-in-the-Prevention-and-Handling-of-Missing-Data-in-Observational-an d-Experimental-Patient-Centered-Outcomes-Research.pdf.
7. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407-15.
8. Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000;21(3):167-89.
9. Evans SR. Fundamentals of clinical trial design. J Exp Stroke Transl Med. 2010;3(1):19-27.
10. Trials PoHMDiC. The Prevention and Treatment of Missing Data in Clinical Trials. National Academy Press; 2010.
11. Can O, Yilmaz A, Hasdogan M, Alkaya F, Turhan S, Can M, et al. Has the quality of abstracts for randomised controlled trials improved since the release of Consolidated Standards of Reporting Trial guideline for abstract reporting? A survey of four high-profile anaesthesia journals. Eur J Anaesthesiol. 2011;28(7):485-92.
12. Rubin DB, Little RJ. Statistical analysis with missing data. Hoboken, NJ: J Wiley & Sons; 2002.
13. Wilkinson L. Task Force on Statistical Inference, APA Board of Scientific Affairs. Statistical methods in psychology journals: Guidelines and explanations. American Psychologist. 1999;54:594-604.
14. Bodner TE. Missing data: prevalence and reporting practices. Psychol Rep. 2006;99(3):675-80.
15. Peugh JL, Enders CK. Missing data in educational research: A review of reporting practices and suggestions for improvement. Review of Educational Research. 2004;74(4):525-56.
16. Enders CK. Applied missing data analysis. New York: The Guilford Press; 2010.
17. Carpenter JR, Kenward MG, Vansteelandt S. A comparison of multiple imputation and doubly robust estimation for analyses with missing data. Journal of the Royal Statistical Society: Series A (Statistics in Society). 2006;169(3):571-84.
18. Beale EM, Little RJ. Missing values in multivariate analysis. Journal of the Royal Statistical Society Series B (Methodological). 1975:129-45.
19. Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581-92.
20. Carpenter JR, Kenward MG. Missing data in randomised controlled trials-a practical guide [Internet]. 2007. Available from: http://www.hta.nhs.uk/nihrmethodology/reports/1589.pdf.
21. Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355-60.
22. NAS. The Prevention and Treatment of Missing Data in Clinical Trials. The National Academies Press; 2010.
23. O'Neill RT, Temple R. The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it. Clin Pharmacol Ther. 2012;91(3):550-4.
24. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987. 278 p.
25. Little RJ, Rubin DB. The analysis of social science data with missing values. Sociological Methods & Research. 1989;18(2-3):292-326.
26. Wisniewski SR, Leon AC, Otto MW, Trivedi MH. Prevention of missing data in clinical research studies. Biol Psychiatry. 2006;59(11):997-1000.
27. Little RJA. A Test of Missing Completely at Random for Multivariate Data with Missing Values. J Am Stat Assoc. 1988;83(404):1198-202.
28. Carpenter J, Pocock S, Johan Lamm C. Coping with missing data in clinical trials: A model-based approach applied to asthma trials. Stat Med. 2002;21(8):1043-66.
29. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2009. 568 p.
30. Liu G, Gould AL. Comparison of alternative strategies for analysis of longitudinal trials with dropouts. J Biopharm Stat. 2002;12(2):207-26.
31. Mallinckrodt CH, Clark WS, David SR. Accounting for dropout bias using mixed-effects models. J Biopharm Stat. 2001;11(1-2):9-21.
32. Lavori PW, Dawson R, Shera D. A multiple imputation strategy for clinical trials with truncation of patient data. Stat Med. 1995;14(17):1913-25.
33. Barnes SA, Mallinckrodt CH, Lindborg SR, Carter MK. The impact of missing data and how it is handled on the rate of false-positive results in drug development. Pharm Sat. 2008;7(3):215-25.
34. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278-95.
35. Raghunathan TE. What do we do with missing data? Some options for analysis of incomplete data. Annu Rev Public Health. 2004;25:99-117.
36. Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet. 2011;378(9785):49-55.
37. Savoye M, Shaw M, Dziura J, Tamborlane WV, Rose P, Guandalini C, et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA. 2007;297(24):2697-704.
38. Allison PD. Multiple imputation for missing data. Sociological Methods & Research. 2000;28(3):301-9.
39. Allison PD. Missing data. Thousand Oaks, CA: Sage Publications; 2002. 93 p.
40. Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303(19):1929-37.
41. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359(7):677-87.
42. Mallinckrodt CH, Sanger TM, Dubé S, De-Brota DJ, Molenberghs G, Carroll RJ, et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry. 2003;53(8):754-60.
43. Little RJ, Wang Y. Pattern-mixture models for multivariate incomplete data with covariates. Biometrics. 1996;52(1):98-111.
44. Mallinckrodt CH, Lin Q, Molenberghs M. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials. Pharm Stat. 2013;12(1):1-6.
45. Jackson D, White IR, Leese M. How much can we learn about missing data?: an exploration of a clinical trial in psychiatry. J R Stat Soc Ser A Stat Soc. 2010;173(3):593-612.
46. Niaura R, Spring B, Borrelli B, Hedeker D, Goldstein MG, Keuthen N, et al. Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychol. 2002;70(4):887-96.
47. Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet. 2002;359(9308):781-5.
48. Kristman V, Manno M, Cote P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2004;19(8):751-60.
49. Hughes S, Harris J, Flack N, Cuffe RL. The statistician's role in the prevention of missing data. Pharm Stat. 2012;11(5):410-6.
50. Guideline on missing data in confirmatory clinical trials. European Medicines Agency [Internet]. 2010. Available from: http://www.ema.europa.eu/docs/en_GB/docume nt_library/Scientific_guide-line/2010/09/WC500096793.pdf.
51. Scharfstein DO, Hogan J, Herman A. On the prevention and analysis of missing data in randomized clinical trials: the state of the art. J Bone Joint Surg Am. 2012;94(Suppl 1):80-4.
52. Amery W, Dony J. A clinical trial design avoiding undue placebo treatment. J Clin Pharmacol. 1975;15(10):674-9.
53. National Institute on Aging. Guidelines for Developing a Manual of Operations and Procedures (MOP) [Internet]. Available from: http://www.nia.nih.gov/research/dgcg/clinical-research-study-investigators-toolbox/startup.